Novartis Gets Health Canada Nod For Fabhalta In Adult C3G
02 May 2026 //
FIRSTWORD PHARMA
FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data
02 May 2026 //
ENDPOINTS
Novartis Reveals North Carolina Factory In $23B US Expansion
02 May 2026 //
ENDPOINTS
US FDA approves Axsome`s drug for Alzheimer`s-related agitation
02 May 2026 //
REUTERS
Weight-loss drugs may also help cut alcohol intake: Study
02 May 2026 //
ECONOMICTIMES
Halozyme To Report Q1 2026 Financial And Operating Results
01 May 2026 //
PR NEWSWIRE
Early sales of Lilly’s obesity pill appear to trail Novo’s
01 May 2026 //
ENDPOINTS
SPARC To Sell Rare Pediatric Disease Priority Review Voucher
01 May 2026 //
EXPRESSPHARMA
Patient death prompts FDA pause on Newron’s Phase 3 schizophrenia
01 May 2026 //
BIOSPACE
Drugs In Development
Market Intel

Market Place
Sourcing Support